Germany · Delayed Price · Currency is EUR Blueberries Medical Statistics
Total Valuation
FRA:1OA has a market cap or net worth of EUR 6.10 million. The enterprise value is 6.01 million.
| Market Cap | 6.10M |
| Enterprise Value | 6.01M |
Important Dates
The last earnings date was Monday, November 24, 2025.
| Earnings Date | Nov 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 495.09M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +23.34% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.54% |
| Owned by Institutions (%) | n/a |
| Float | 150.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.08 |
| PB Ratio | 13.00 |
| P/TBV Ratio | 13.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.32 |
| EV / Sales | 23.58 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.10, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.10 |
| Quick Ratio | 0.61 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18,297.07 |
Financial Efficiency
Return on equity (ROE) is -155.46% and return on invested capital (ROIC) is -83.19%.
| Return on Equity (ROE) | -155.46% |
| Return on Assets (ROA) | -58.95% |
| Return on Invested Capital (ROIC) | -83.19% |
| Return on Capital Employed (ROCE) | -175.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.09 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +20.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +20.00% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 27.41 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:1OA had revenue of EUR 253,307 and -950,805 in losses. Loss per share was -0.00.
| Revenue | 253,307 |
| Gross Profit | 93,470 |
| Operating Income | -823,368 |
| Pretax Income | -950,805 |
| Net Income | -950,805 |
| EBITDA | -761,151 |
| EBIT | -823,368 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 14,570 in cash and 6,744 in debt, giving a net cash position of 7,826.
| Cash & Cash Equivalents | 14,570 |
| Total Debt | 6,744 |
| Net Cash | 7,826 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 469,309 |
| Book Value Per Share | 0.00 |
| Working Capital | 274,638 |
Cash Flow
| Operating Cash Flow | -800,260 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 36.90% |
| Operating Margin | -325.05% |
| Pretax Margin | -375.36% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:1OA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.34% |
| Shareholder Yield | -23.34% |
| Earnings Yield | -15.59% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:1OA has an Altman Z-Score of -26.46 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -26.46 |
| Piotroski F-Score | 2 |